UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Form 8-K

 

Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 23, 2010

 


 

Senomyx, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-50791

 

33-0843840

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

 

4767 Nexus Centre Drive
San Diego, California

 

92121

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (858) 646-8300

 

Not Applicable.

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 8.01               Other Events.

 

On March 23, 2010 Campbell Soup Company exercised their option to extend the collaborative research period under our Collaborative Research and License Agreement dated March 28, 2001, as amended, for an additional year (through March 28, 2011).  During the extension period, we will continue to work with Campbell on the discovery and commercialization of new ingredients for use in wet soups and savory beverages and Campbell will continue to provide incremental research funding.  Following this first option exercise, Campbell now retains two annual options of one year each that could further extend the collaborative period for up to two additional years. The other material terms of the agreement remain unchanged.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

SENOMYX, INC.

 

 

 

 

 

By:

/S/ DAVID BERGER

 

 

 

David Berger

 

 

 

Vice President, General Counsel and Corporate Secretary

 

 

 

Date:  March 25, 2010

 

 

 

3